Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest CRISPR Therapeutics AG (CRSP) stock news and headlines to help you in your trading and investing decisions.

Dec 30, 2024 · The CRISPR technology market is poised for explosive growth. Coherent Market Insights estimates it will be worth $3.64 billion in 2024 and climb to more than $12.46 billion by 2031, growing at an ...

Nov 20, 2024 · In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other genomics stocks. Genomics is the study of genes and how they function.

Jan 7, 2025 · CRISPR Therapeutics AG (CRSP) ended the recent trading session at $41.92, demonstrating a -1.2% swing from the preceding day's closing price.

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ...

Dec 29, 2024 · In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other gene therapy stocks.

Oct 31, 2024 · In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other most promising gene editing stocks to buy according to hedge funds.

Dec 31, 2024 · The most recent trading session ended with CRISPR Therapeutics AG (CRSP) standing at $39.36, reflecting a +1.84% shift from the previouse trading day's closing.

See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.